id todo:paper_03785173_v556_n_p9_Masotta
record_format dspace
spelling todo:paper_03785173_v556_n_p9_Masotta2023-10-03T15:33:09Z High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation Masotta, N.E. Martinefski, M.R. Lucangioli, S. Rojas, A.M. Tripodi, V.P. Coenzyme Q10 (PubChem CID: 9962735) Coenzyme Q10 stability Coenzyme Q10 treatment Dynamic rheology Dysphagia Ethylcellulose Ethylcellulose (PubChem CID: 24832091) High-dose coenzyme Q10 Lecithin from soybean (PubChem CID: 57369748) MCT oil (PubChem CID: 93356) Oleogels SMS or sorbitan monostearate or Span 60 (PubChem CID: 14928) ethyl cellulose medium chain triacylglycerol phosphatidylcholine ubidecarenone Article bulk density controlled study drug absorption drug formulation drug megadose drug solubility gel glass transition temperature human hydrogen bond kidney disease melting point oleogel priority journal supplementation viscosity Coenzyme Q10 (CoQ10) is a mitochondrial respiratory cofactor and potent endogenous antioxidant. In CoQ10-deficient patients, early treatment with high-oral doses (5–50 mg/kg/day) can limit the progression of renal disease and the onset of neurological manifestations. Crystalline CoQ10 is lipophilic, water-insoluble, and poorly absorbed in the gut. Here, CoQ10 showed low bulk density, another important disadvantage in solid oral formulations. Thus, we propose the use of oleogels to maintain dissolved a high-dose of CoQ10 in medium-chain triglyceride (MCT) oil, using ethylcellulose (EC) for gelling, and a surfactant (sorbitan monostearate –SMS- or lecithin). “True gels” were only obtained with the surfactant presence. Thermoreversible oleogels with 1 g of dissolved CoQ10 per 5 g-disk were successfully developed with proved stability and solubility for 12 months (25.0 °C). SMS was better than lecithin as a surfactant because it allowed lower syneresis, higher CoQ10 retention for 12 months, and notably higher oxidative-stability of the MCT-oil, best immobilized by its true gel network. Plastic deformation without fracture was determined under compression, emulating the soft deformation behavior inside the mouth. SMS-oleogels allowed loading a maximal solubilized CoQ10 dose with maximal stability, and may be easier to swallow by CoQ10-deficient patients who suffer from secondary dysphagia. © 2018 Elsevier B.V. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_03785173_v556_n_p9_Masotta
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Coenzyme Q10 (PubChem CID: 9962735)
Coenzyme Q10 stability
Coenzyme Q10 treatment
Dynamic rheology
Dysphagia
Ethylcellulose
Ethylcellulose (PubChem CID: 24832091)
High-dose coenzyme Q10
Lecithin from soybean (PubChem CID: 57369748)
MCT oil (PubChem CID: 93356)
Oleogels
SMS or sorbitan monostearate or Span 60 (PubChem CID: 14928)
ethyl cellulose
medium chain triacylglycerol
phosphatidylcholine
ubidecarenone
Article
bulk density
controlled study
drug absorption
drug formulation
drug megadose
drug solubility
gel
glass transition temperature
human
hydrogen bond
kidney disease
melting point
oleogel
priority journal
supplementation
viscosity
spellingShingle Coenzyme Q10 (PubChem CID: 9962735)
Coenzyme Q10 stability
Coenzyme Q10 treatment
Dynamic rheology
Dysphagia
Ethylcellulose
Ethylcellulose (PubChem CID: 24832091)
High-dose coenzyme Q10
Lecithin from soybean (PubChem CID: 57369748)
MCT oil (PubChem CID: 93356)
Oleogels
SMS or sorbitan monostearate or Span 60 (PubChem CID: 14928)
ethyl cellulose
medium chain triacylglycerol
phosphatidylcholine
ubidecarenone
Article
bulk density
controlled study
drug absorption
drug formulation
drug megadose
drug solubility
gel
glass transition temperature
human
hydrogen bond
kidney disease
melting point
oleogel
priority journal
supplementation
viscosity
Masotta, N.E.
Martinefski, M.R.
Lucangioli, S.
Rojas, A.M.
Tripodi, V.P.
High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation
topic_facet Coenzyme Q10 (PubChem CID: 9962735)
Coenzyme Q10 stability
Coenzyme Q10 treatment
Dynamic rheology
Dysphagia
Ethylcellulose
Ethylcellulose (PubChem CID: 24832091)
High-dose coenzyme Q10
Lecithin from soybean (PubChem CID: 57369748)
MCT oil (PubChem CID: 93356)
Oleogels
SMS or sorbitan monostearate or Span 60 (PubChem CID: 14928)
ethyl cellulose
medium chain triacylglycerol
phosphatidylcholine
ubidecarenone
Article
bulk density
controlled study
drug absorption
drug formulation
drug megadose
drug solubility
gel
glass transition temperature
human
hydrogen bond
kidney disease
melting point
oleogel
priority journal
supplementation
viscosity
description Coenzyme Q10 (CoQ10) is a mitochondrial respiratory cofactor and potent endogenous antioxidant. In CoQ10-deficient patients, early treatment with high-oral doses (5–50 mg/kg/day) can limit the progression of renal disease and the onset of neurological manifestations. Crystalline CoQ10 is lipophilic, water-insoluble, and poorly absorbed in the gut. Here, CoQ10 showed low bulk density, another important disadvantage in solid oral formulations. Thus, we propose the use of oleogels to maintain dissolved a high-dose of CoQ10 in medium-chain triglyceride (MCT) oil, using ethylcellulose (EC) for gelling, and a surfactant (sorbitan monostearate –SMS- or lecithin). “True gels” were only obtained with the surfactant presence. Thermoreversible oleogels with 1 g of dissolved CoQ10 per 5 g-disk were successfully developed with proved stability and solubility for 12 months (25.0 °C). SMS was better than lecithin as a surfactant because it allowed lower syneresis, higher CoQ10 retention for 12 months, and notably higher oxidative-stability of the MCT-oil, best immobilized by its true gel network. Plastic deformation without fracture was determined under compression, emulating the soft deformation behavior inside the mouth. SMS-oleogels allowed loading a maximal solubilized CoQ10 dose with maximal stability, and may be easier to swallow by CoQ10-deficient patients who suffer from secondary dysphagia. © 2018 Elsevier B.V.
format JOUR
author Masotta, N.E.
Martinefski, M.R.
Lucangioli, S.
Rojas, A.M.
Tripodi, V.P.
author_facet Masotta, N.E.
Martinefski, M.R.
Lucangioli, S.
Rojas, A.M.
Tripodi, V.P.
author_sort Masotta, N.E.
title High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation
title_short High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation
title_full High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation
title_fullStr High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation
title_full_unstemmed High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation
title_sort high-dose coenzyme q10-loaded oleogels for oral therapeutic supplementation
url http://hdl.handle.net/20.500.12110/paper_03785173_v556_n_p9_Masotta
work_keys_str_mv AT masottane highdosecoenzymeq10loadedoleogelsfororaltherapeuticsupplementation
AT martinefskimr highdosecoenzymeq10loadedoleogelsfororaltherapeuticsupplementation
AT lucangiolis highdosecoenzymeq10loadedoleogelsfororaltherapeuticsupplementation
AT rojasam highdosecoenzymeq10loadedoleogelsfororaltherapeuticsupplementation
AT tripodivp highdosecoenzymeq10loadedoleogelsfororaltherapeuticsupplementation
_version_ 1807320853283602432